News
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.
4don MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results